1.
Scott H. Kaufmann, Judith E. Karp, Mark R. Litzow, Ruben A. Mesa, William Hogan, David P. Steensma, Karen S. Flatten, David A. Loegering, Paula A. Schneider, Kevin L. Peterson, Matthew J. Maurer, B. Douglas Smith, Jacqueline Greer, Yuhong Chen, Joel M. Reid, S. Percy Ivy, Matthew M. Ames, Alex A. Adjei, Charles Erlichman, Larry M. Karnitz. Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia. haematol [Internet]. 2011Nov.4 [cited 2024Apr.26];96(11):1619-26. Available from: https://haematologica.org/article/view/6120